A Northwestern University team has developed a method of optimising spherical nucleic acids, which could revolutionise nanomedicine for cancer immunotherapy in the future.
Spherical nucleic acids are digitally designed nanostructures, which have DNA and RNA arranged on a nanoparticle’s surface. They have the ability to treat a wide range of diseases, but there is a need to optimise their components before they can be used for these potential purposes.
CC0 Creative Commons, Pixabay
The post Nanomedicine for cancer immunotherapy: Spherical nucleic acids appeared first on Healthier Environment Living Program.